Dermatology OTC Medications Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (External Use, Oral); Applications (Hospital, Drug Store, Other)
Report Code: TIPRE00010460 No. of Pages: 150 Category: Healthcare IT Status: Upcoming
MARKET INTRODUCTION
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.
MARKET DYNAMICS
The dermatology OTC medications market is anticipated to grow due to increasing incidences and awareness of cardiovascular diseases in the Asia Pacific region. Moreover, changing lifestyle, increased smoking, rising prevalence of strokes, and increasing technological advancements in the medical devices industry is expected to boost the growth of the market in the forecast period.
MARKET SCOPE
The "Dermatology OTC Medications Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of in dermatology OTC medications market with detailed market segmentation by type, application. The dermatology OTC medications market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in dermatology OTC medications market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The dermatology OTC medications market is segmented on the basis of type, and application. Based on type the market is segmented as external use and oral. On the basis of application the market is categorized as hospitals, drug store and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in dermatology OTC medications market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dermatology OTC medications market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dermatology OTC medications market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dermatology OTC medications market in these regions.
The report covers key developments in the in dermatology OTC medications market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in dermatology OTC medications market are anticipated to have lucrative growth opportunities in the future with the rising demand for in dermatology OTC medications market in the global market. Below mentioned is the list of few companies engaged in the dermatology OTC medications market.
The report also includes the profiles of key in dermatology OTC medications market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.
MARKET DYNAMICS
The dermatology OTC medications market is anticipated to grow due to increasing incidences and awareness of cardiovascular diseases in the Asia Pacific region. Moreover, changing lifestyle, increased smoking, rising prevalence of strokes, and increasing technological advancements in the medical devices industry is expected to boost the growth of the market in the forecast period.
MARKET SCOPE
The "Dermatology OTC Medications Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of in dermatology OTC medications market with detailed market segmentation by type, application. The dermatology OTC medications market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in dermatology OTC medications market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The dermatology OTC medications market is segmented on the basis of type, and application. Based on type the market is segmented as external use and oral. On the basis of application the market is categorized as hospitals, drug store and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in dermatology OTC medications market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dermatology OTC medications market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dermatology OTC medications market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dermatology OTC medications market in these regions.
The report covers key developments in the in dermatology OTC medications market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in dermatology OTC medications market are anticipated to have lucrative growth opportunities in the future with the rising demand for in dermatology OTC medications market in the global market. Below mentioned is the list of few companies engaged in the dermatology OTC medications market.
The report also includes the profiles of key in dermatology OTC medications market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bayer AG
- Aurobindo Pharma
- Cipla Inc.
- Galderma
- GlaxoSmithKline plc.
- Lupin Pharmaceuticals, Inc.
- Mylan N.V
- Novartis AG
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dermatology OTC Medications Market - By Type
1.3.2 Dermatology OTC Medications Market - By Applications
1.3.3 Dermatology OTC Medications Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DERMATOLOGY OTC MEDICATIONS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DERMATOLOGY OTC MEDICATIONS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DERMATOLOGY OTC MEDICATIONS MARKET - GLOBAL MARKET ANALYSIS
6.1. DERMATOLOGY OTC MEDICATIONS - GLOBAL MARKET OVERVIEW
6.2. DERMATOLOGY OTC MEDICATIONS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DERMATOLOGY OTC MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. EXTERNAL USE
7.3.1. Overview
7.3.2. External Use Market Forecast and Analysis
7.4. ORAL
7.4.1. Overview
7.4.2. Oral Market Forecast and Analysis
8. DERMATOLOGY OTC MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. DRUG STORE
8.4.1. Overview
8.4.2. Drug Store Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. DERMATOLOGY OTC MEDICATIONS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Dermatology OTC Medications Market Overview
9.1.2 North America Dermatology OTC Medications Market Forecasts and Analysis
9.1.3 North America Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.1.4 North America Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.1.5 North America Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dermatology OTC Medications Market
9.1.5.1.1 United States Dermatology OTC Medications Market by Type
9.1.5.1.2 United States Dermatology OTC Medications Market by Applications
9.1.5.2 Canada Dermatology OTC Medications Market
9.1.5.2.1 Canada Dermatology OTC Medications Market by Type
9.1.5.2.2 Canada Dermatology OTC Medications Market by Applications
9.1.5.3 Mexico Dermatology OTC Medications Market
9.1.5.3.1 Mexico Dermatology OTC Medications Market by Type
9.1.5.3.2 Mexico Dermatology OTC Medications Market by Applications
9.2. EUROPE
9.2.1 Europe Dermatology OTC Medications Market Overview
9.2.2 Europe Dermatology OTC Medications Market Forecasts and Analysis
9.2.3 Europe Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.2.4 Europe Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.2.5 Europe Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dermatology OTC Medications Market
9.2.5.1.1 Germany Dermatology OTC Medications Market by Type
9.2.5.1.2 Germany Dermatology OTC Medications Market by Applications
9.2.5.2 France Dermatology OTC Medications Market
9.2.5.2.1 France Dermatology OTC Medications Market by Type
9.2.5.2.2 France Dermatology OTC Medications Market by Applications
9.2.5.3 Italy Dermatology OTC Medications Market
9.2.5.3.1 Italy Dermatology OTC Medications Market by Type
9.2.5.3.2 Italy Dermatology OTC Medications Market by Applications
9.2.5.4 Spain Dermatology OTC Medications Market
9.2.5.4.1 Spain Dermatology OTC Medications Market by Type
9.2.5.4.2 Spain Dermatology OTC Medications Market by Applications
9.2.5.5 United Kingdom Dermatology OTC Medications Market
9.2.5.5.1 United Kingdom Dermatology OTC Medications Market by Type
9.2.5.5.2 United Kingdom Dermatology OTC Medications Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dermatology OTC Medications Market Overview
9.3.2 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis
9.3.3 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dermatology OTC Medications Market
9.3.5.1.1 Australia Dermatology OTC Medications Market by Type
9.3.5.1.2 Australia Dermatology OTC Medications Market by Applications
9.3.5.2 China Dermatology OTC Medications Market
9.3.5.2.1 China Dermatology OTC Medications Market by Type
9.3.5.2.2 China Dermatology OTC Medications Market by Applications
9.3.5.3 India Dermatology OTC Medications Market
9.3.5.3.1 India Dermatology OTC Medications Market by Type
9.3.5.3.2 India Dermatology OTC Medications Market by Applications
9.3.5.4 Japan Dermatology OTC Medications Market
9.3.5.4.1 Japan Dermatology OTC Medications Market by Type
9.3.5.4.2 Japan Dermatology OTC Medications Market by Applications
9.3.5.5 South Korea Dermatology OTC Medications Market
9.3.5.5.1 South Korea Dermatology OTC Medications Market by Type
9.3.5.5.2 South Korea Dermatology OTC Medications Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dermatology OTC Medications Market Overview
9.4.2 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis
9.4.3 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dermatology OTC Medications Market
9.4.5.1.1 South Africa Dermatology OTC Medications Market by Type
9.4.5.1.2 South Africa Dermatology OTC Medications Market by Applications
9.4.5.2 Saudi Arabia Dermatology OTC Medications Market
9.4.5.2.1 Saudi Arabia Dermatology OTC Medications Market by Type
9.4.5.2.2 Saudi Arabia Dermatology OTC Medications Market by Applications
9.4.5.3 U.A.E Dermatology OTC Medications Market
9.4.5.3.1 U.A.E Dermatology OTC Medications Market by Type
9.4.5.3.2 U.A.E Dermatology OTC Medications Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dermatology OTC Medications Market Overview
9.5.2 South and Central America Dermatology OTC Medications Market Forecasts and Analysis
9.5.3 South and Central America Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.5.4 South and Central America Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Dermatology OTC Medications Market
9.5.5.1.1 Brazil Dermatology OTC Medications Market by Type
9.5.5.1.2 Brazil Dermatology OTC Medications Market by Applications
9.5.5.2 Argentina Dermatology OTC Medications Market
9.5.5.2.1 Argentina Dermatology OTC Medications Market by Type
9.5.5.2.2 Argentina Dermatology OTC Medications Market by Applications
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DERMATOLOGY OTC MEDICATIONS MARKET, KEY COMPANY PROFILES
11.1. BAYER AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AUROBINDO PHARMA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CIPLA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GALDERMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LUPIN PHARMACEUTICALS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MYLAN N.V
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUN PHARMACEUTICAL INDUSTRIES LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dermatology OTC Medications Market - By Type
1.3.2 Dermatology OTC Medications Market - By Applications
1.3.3 Dermatology OTC Medications Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DERMATOLOGY OTC MEDICATIONS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DERMATOLOGY OTC MEDICATIONS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DERMATOLOGY OTC MEDICATIONS MARKET - GLOBAL MARKET ANALYSIS
6.1. DERMATOLOGY OTC MEDICATIONS - GLOBAL MARKET OVERVIEW
6.2. DERMATOLOGY OTC MEDICATIONS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DERMATOLOGY OTC MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. EXTERNAL USE
7.3.1. Overview
7.3.2. External Use Market Forecast and Analysis
7.4. ORAL
7.4.1. Overview
7.4.2. Oral Market Forecast and Analysis
8. DERMATOLOGY OTC MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. DRUG STORE
8.4.1. Overview
8.4.2. Drug Store Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. DERMATOLOGY OTC MEDICATIONS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Dermatology OTC Medications Market Overview
9.1.2 North America Dermatology OTC Medications Market Forecasts and Analysis
9.1.3 North America Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.1.4 North America Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.1.5 North America Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dermatology OTC Medications Market
9.1.5.1.1 United States Dermatology OTC Medications Market by Type
9.1.5.1.2 United States Dermatology OTC Medications Market by Applications
9.1.5.2 Canada Dermatology OTC Medications Market
9.1.5.2.1 Canada Dermatology OTC Medications Market by Type
9.1.5.2.2 Canada Dermatology OTC Medications Market by Applications
9.1.5.3 Mexico Dermatology OTC Medications Market
9.1.5.3.1 Mexico Dermatology OTC Medications Market by Type
9.1.5.3.2 Mexico Dermatology OTC Medications Market by Applications
9.2. EUROPE
9.2.1 Europe Dermatology OTC Medications Market Overview
9.2.2 Europe Dermatology OTC Medications Market Forecasts and Analysis
9.2.3 Europe Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.2.4 Europe Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.2.5 Europe Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dermatology OTC Medications Market
9.2.5.1.1 Germany Dermatology OTC Medications Market by Type
9.2.5.1.2 Germany Dermatology OTC Medications Market by Applications
9.2.5.2 France Dermatology OTC Medications Market
9.2.5.2.1 France Dermatology OTC Medications Market by Type
9.2.5.2.2 France Dermatology OTC Medications Market by Applications
9.2.5.3 Italy Dermatology OTC Medications Market
9.2.5.3.1 Italy Dermatology OTC Medications Market by Type
9.2.5.3.2 Italy Dermatology OTC Medications Market by Applications
9.2.5.4 Spain Dermatology OTC Medications Market
9.2.5.4.1 Spain Dermatology OTC Medications Market by Type
9.2.5.4.2 Spain Dermatology OTC Medications Market by Applications
9.2.5.5 United Kingdom Dermatology OTC Medications Market
9.2.5.5.1 United Kingdom Dermatology OTC Medications Market by Type
9.2.5.5.2 United Kingdom Dermatology OTC Medications Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dermatology OTC Medications Market Overview
9.3.2 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis
9.3.3 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dermatology OTC Medications Market
9.3.5.1.1 Australia Dermatology OTC Medications Market by Type
9.3.5.1.2 Australia Dermatology OTC Medications Market by Applications
9.3.5.2 China Dermatology OTC Medications Market
9.3.5.2.1 China Dermatology OTC Medications Market by Type
9.3.5.2.2 China Dermatology OTC Medications Market by Applications
9.3.5.3 India Dermatology OTC Medications Market
9.3.5.3.1 India Dermatology OTC Medications Market by Type
9.3.5.3.2 India Dermatology OTC Medications Market by Applications
9.3.5.4 Japan Dermatology OTC Medications Market
9.3.5.4.1 Japan Dermatology OTC Medications Market by Type
9.3.5.4.2 Japan Dermatology OTC Medications Market by Applications
9.3.5.5 South Korea Dermatology OTC Medications Market
9.3.5.5.1 South Korea Dermatology OTC Medications Market by Type
9.3.5.5.2 South Korea Dermatology OTC Medications Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dermatology OTC Medications Market Overview
9.4.2 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis
9.4.3 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dermatology OTC Medications Market
9.4.5.1.1 South Africa Dermatology OTC Medications Market by Type
9.4.5.1.2 South Africa Dermatology OTC Medications Market by Applications
9.4.5.2 Saudi Arabia Dermatology OTC Medications Market
9.4.5.2.1 Saudi Arabia Dermatology OTC Medications Market by Type
9.4.5.2.2 Saudi Arabia Dermatology OTC Medications Market by Applications
9.4.5.3 U.A.E Dermatology OTC Medications Market
9.4.5.3.1 U.A.E Dermatology OTC Medications Market by Type
9.4.5.3.2 U.A.E Dermatology OTC Medications Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dermatology OTC Medications Market Overview
9.5.2 South and Central America Dermatology OTC Medications Market Forecasts and Analysis
9.5.3 South and Central America Dermatology OTC Medications Market Forecasts and Analysis - By Type
9.5.4 South and Central America Dermatology OTC Medications Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Dermatology OTC Medications Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Dermatology OTC Medications Market
9.5.5.1.1 Brazil Dermatology OTC Medications Market by Type
9.5.5.1.2 Brazil Dermatology OTC Medications Market by Applications
9.5.5.2 Argentina Dermatology OTC Medications Market
9.5.5.2.1 Argentina Dermatology OTC Medications Market by Type
9.5.5.2.2 Argentina Dermatology OTC Medications Market by Applications
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DERMATOLOGY OTC MEDICATIONS MARKET, KEY COMPANY PROFILES
11.1. BAYER AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AUROBINDO PHARMA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CIPLA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GALDERMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LUPIN PHARMACEUTICALS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MYLAN N.V
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUN PHARMACEUTICAL INDUSTRIES LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Bayer AG
2. Aurobindo Pharma
3. Cipla Inc.
4. Galderma
5. GlaxoSmithKline plc.
6. Lupin Pharmaceuticals, Inc.
7. Mylan N.V
8. Novartis AG
9. Sun Pharmaceutical Industries Limited
10. Teva Pharmaceutical Industries Ltd.
1. Bayer AG
2. Aurobindo Pharma
3. Cipla Inc.
4. Galderma
5. GlaxoSmithKline plc.
6. Lupin Pharmaceuticals, Inc.
7. Mylan N.V
8. Novartis AG
9. Sun Pharmaceutical Industries Limited
10. Teva Pharmaceutical Industries Ltd.